Clinical Characteristics and Management of Sudden Sensorineural Hearing Loss

다국어 초록 (Multilingual Abstract)

Sudden sensorineural hearing loss (SSNHL) is characterized by abrupt unilateral loss of hearing, sometimes accompanied by tinnitus or vertigo. From the majority of patients with SSNHL, no specific cause can be identified, but numerous conditions including viral infection, vascular compromise and intracochlear membrane break are considered as possible causes of disease. According to these etiologic hypotheses, a combination therapy has been frequently used combining several options among steroids, antiviral agents, vasodilators, volume expanders, stellate ganglion block and carbogen or hyperbaric oxygen. The contents of the combination could vary according to the experience of each clinic, but steroids have been accepted as the mainstay of the treatment for SSNHL since Wilson's landmark study although two recent meta-analysis of steroid treatment suggested there was no benefit. The amount and the length of oral steroid therapy have not been well established. Commonly used regimen of oral steroid therapy is prednisone. A reported success rate with systemic steroid therapy is between 49% and 89%, whereas only 30% to 65% of patients without treatment achieved hearing improvement. Recently there is an obvious trend for an increasing number of positive results of intratympanic steroids injection. It is difficult to evaluate the efficacy of a certain drug or regimen prescribed for SSNHL because of various drugs used as combination therapy, many prognostic factors and different inclusion criteria.

참고문헌 (Reference)

1 문영은, "소아 돌발성 난청의 임상 양상과 치료결과" 대한이비인후과학회 52 (52): 805-809, 2009

2 신시옥, "돌발성 난청 환자에서 부신 피질 호르몬제 단독 투여와 Acyclovir동시 투여의 치료 효과 비교" 대한이비인후과학회 45 (45): 225-230, 2002

3 Conlin AE, "Treatment of sudden sensorineural hearing loss: II. A Meta-analysis" 133 : 582-586, 2007

4 Lautermann J, "Transtympanic corticoid therapy for acute profound hearing loss" 262 : 587-591, 2005

5 Siegel LG, "The treatment of idiopathic sudden sensorineural hearing loss" 8 : 467-473, 1975

6 Wilson WR, "The relationship of the herpesvirus family to sudden hearing loss: a prospective clinical study and literature review" 96 : 870-877, 1986

7 Stokroos RJ, "The etiology of idiopathic sudden sensorineural hearing loss. Experimental herpes simplex virus infection of the inner ear" 19 : 447-452, 1998

8 Wilson WR, "The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical stu-dy" 106 : 772-776, 1980

9 Shin SO, "The efficacy of an additional cycle of oral steroids in partially recovered sudden sensorineural hearing loss (SSNHL) after initial oral steroid therapy" 2007 : 49-53, 2007

10 Sauvaget E, "Sudden sensorineural hearing loss as a revealing symptom of vestibular sch-wannoma" 125 : 592-595, 2005

11 Hughes GB, "Sudden sensorineural hearing loss" 29 : 393-405, 1996

12 Shaia FT, "Sudden sensori-neural hearing impairment: a report of 1,220 cases" 86 : 389-398, 1976

13 Byl FM Jr, "Sudden hearing loss: eight years’ experience and suggested prognostic table" 94 : 647-661, 1984

14 Chaimoff M, "Sudden hearing loss as a presenting symptom of acoustic neuroma" 20 : 157-160, 1999

15 Moskowitz D, "Smith HW. Steroid use in idiopathic sudden sensorineural hearing loss" 94 : 664-666, 1984

16 Rarey KE, "Receptors for glucocorticoids in the human inner ear" 115 : 38-41, 1996

17 Ito S, "Prognosis is predicted by early hearing improvement in patients with idiopathic sudden sensorineural hearing loss" 27 : 501-504, 2002

18 Fetterman BL, "Prognosis and treatment of sudden sensorineural hearing loss" 17 : 529-536, 1996

19 Chen CY, "Oral steroid treatment of sudden sensorineural hearing loss: a ten year retrospective analysis" 24 : 728-733, 2003

20 Slattery WH, "Oral steroid regimens for idiopathic sudden sensorineural hearing loss" 132 : 5-10, 2005

21 Mattox DE, "Natural history of sudden sensorineural hearing loss" 86 : 463-480, 1977

22 Labus J, "Meta-analysis for the effect of medical therapy vs. placebo on recovery of idiopathic sudden hearing loss" 120 : 1863-1871, 2010

23 Rauch SD, "Intratympanic steroids for sensorineural hearing loss" 37 : 1061-1074, 2004

24 Silverstein H, "Intratympanic steroid treatment of inner ear disease and tinnitus (preliminary report)" 75 : 468-476, 1996

25 Alles MJ, "Intratympanic steroid therapy for inner ear diseases, a review of the literature" 263 : 791-797, 2006

26 Chandrasekhar SS, "Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation" 22 : 18-23, 2001

27 Haynes DS, "Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy" 117 : 3-15, 2007

28 Battista RA, "Intratympanic dexamethasone for profound idiopathic sudden sensorineural hearing loss" 132 : 902-905, 2005

29 Minoda R, "Initial steroid hormone dose in the treatment of idiopathic sudden deafness" 21 : 819-825, 2000

30 Whitaker S, "Idiopathic sudden hearing loss" 1 : 180-183, 1980

31 Wilkins SA Jr, "Evaluation of a “shotgun” regimen for sudden hearing loss" 97 : 474-480, 1987

32 Rambold H, "Differential vestibular dysfunction in sudden unilateral hearing loss" 64 : 148-151, 2005

33 Zadeh MH, "Diagnosis and treatment of sudden-onset sensorineural hearing loss: a study of 51 patients" 128 : 92-98, 2003

34 Chandrasekhar SS, "Dexamethasone pharmacokinetics in the inner ear: comparison of route of administration and use of facilitating agents" 122 : 521-528, 2000

35 Schweinfurth JM, "Current concepts in the diagnosis and treatment of sudden sensorineural hearing loss" 117 (117): 117-121, 1996

36 Parnes LS, "Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application" 109 : 1-17, 1999

37 Cadoni G, "Coenzyme Q 10 and cardiovascular risk factors in idiopathic sudden sensorineural hearing loss patients" 28 : 878-883, 2007

38 Daniels RL, "Causes of unilateral sensorineural hearing loss screened by high-resolution fast spin echo magnetic resonance imaging: review of 1,070 consecutive cases" 21 : 173-180, 2000

39 Robinette MS, "Auditory brainstem response and magnetic resonance imaging for acoustic neuromas: costs by prevalence" 126 : 963-966, 2000

40 Ottaviani F, "Anti-endothelial autoantibodies in patients with sudden hearing loss" 109 : 1084-1087, 1999

41 Nageris BI, "Acoustic neuroma in patients with completely resolved sudden hearing loss" 112 : 395-397, 2003